ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,113.72
0.27%
US Tech 100
17,305.60
0.38%
다우존스 지수
38,375.56
0.36%
Bitcoin
62,949.12
-0.08%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Avadel Pharmaceuticals PLC (AVDL)

  7. Avadel Pharmaceuticals PLC (AVDL) 뉴스

AVDL Avadel Pharmaceuticals PLC

18.235
0.425 (2.39%)
최종 업데이트: 03:03:12
15분 지연
기업명 주식 심볼 시장 주식 타입
Avadel Pharmaceuticals PLC AVDL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.425 2.39% 18.235 03:03:12
개장가 저가 고가 종가 전일 종가
17.93 17.82 18.26 17.81
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/04/202421:00GLOBEAvadel Pharmaceuticals to Present at the 23rd Annual Needham..
05/03/202422:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
05/03/202405:51EDGAR2Form 8-K - Current report
05/03/202405:37GLOBEAvadel Pharmaceuticals Issues Statement On Patent Litigation
04/03/202420:35EDGAR2Form 8-K - Current report
04/03/202420:30GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
04/03/202420:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/03/202420:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/03/202420:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/02/202422:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
14/02/202421:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202407:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202406:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202423:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/02/202422:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/02/202422:00GLOBEAvadel Pharmaceuticals to Present at the Oppenheimer 34th..
17/01/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202421:20EDGAR2Form 8-K - Current report
08/01/202421:00GLOBEAvadel Pharmaceuticals Announces Strong LUMRYZ Launch..
30/12/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202304:54EDGAR2Form 144 - Report of proposed sale of securities
08/11/202323:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202321:09EDGAR2Form 8-K - Current report
08/11/202321:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
07/11/202322:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
30/10/202321:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
20/10/202321:00GLOBEAvadel Pharmaceuticals Announces Data Supporting Clinical..
05/10/202321:00GLOBEAvadel Pharmaceuticals to Present at the Jefferies Biotech..
02/09/202310:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/09/202310:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/08/202321:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
16/08/202305:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202306:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202305:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202304:50EDGAR2Form 144 - Report of proposed sale of securities
11/08/202307:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202322:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202320:37EDGAR2Form 8-K - Current report
09/08/202320:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
04/08/202305:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/08/202305:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/08/202305:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/08/202305:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/08/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/08/202305:15EDGAR2Form 8-K - Current report
04/08/202305:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..
03/08/202320:30EDGAR2Form 8-K - Current report
02/08/202321:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
21/07/202305:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..
07/07/202305:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..

최근 히스토리

NASDAQ
AVDL
Avadel Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유